Overall, these findings suggested that targeting the compensatory increase in Nrf2 due to NPL4 inhibition enhances DSF/Cu-induced oxidative stress and ferroptosis in RCC (Table 2 and Table 3) [144]. The gene discussed is NPLOC4; the disease is renal cell carcinoma.